72.11.Z - Scientific research and development activities
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
62.01.Z - Activities related to programming, IT consulting, and related activities
70.22.Z - Head office activities and management consultancy
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 34 | 139,5 | 258,4 | 85,2 |
Gross profit (loss) | -0,6 | 9,8 | 11,8 | 20,7 |
Net profit (loss) | 0,1 | 10,9 | 12,6 | 16,5 |
Cash | 3,5 | 72,6 | 19,6 | -73 |
Liabilities and provisions for liabilities | 16,5 | 25,8 | 131,9 | 410,2 |
Net income from sale | 17,5 | 80 | 111,2 | 39,1 |
Short time liabilities | 10,8 | 15,5 | 33,7 | 117,3 |
Working assets | 19,4 | 108,6 | 71,5 | -34,1 |
Equity capital | 17,5 | 113,7 | 126,6 | 11,3 |
Operating profit (EBIT) | -0,4 | -1,6 | 11 | 768,5 |
% | % | % | p.p. | |
Equity capital to total assets | 51,4 | 81,5 | 49 | -32,5 |
Gross profit margin | -3,6 | 12,2 | 10,6 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 225 | 71 | 111 | 40 |
Current financial liquidity indicator | 1.3421735763549805 | 5.384759426116943 | 1.6540361642837524 | -3,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane